Cargando…
A prospective, single-arm, phase II clinical trial of intraoperative radiotherapy using a low-energy X-ray source for local advanced Laryngocarcinoma (ILAL): a study protocol
BACKGROUND: Laryngocarcinoma (LC), in most cases a squamous cell carcinoma, accounts for 1 ~ 5% of the incidence of all tumors. At present, laryngocarcinoma is mainly managed with the integration of surgery and radio- and chemo-therapies. The current development trend of treatment is to improve the...
Autores principales: | Yang, Yining, Li, Li, Zheng, Yongzhe, Liu, Qingfeng, Wei, Xianfeng, Gong, Xinyuan, Wang, Wei, Lin, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409502/ https://www.ncbi.nlm.nih.gov/pubmed/32762662 http://dx.doi.org/10.1186/s12885-020-07233-1 |
Ejemplares similares
-
Expression and role of EGFR, cyclin D1 and KRAS in laryngocarcinoma tissues
por: Lin, Xinsheng, et al.
Publicado: (2019) -
Expression of endothelin-1 in laryngocarcinoma tissues and its clinical significance
por: WANG, SHAOZHONG, et al.
Publicado: (2016) -
Liriodenine induces the apoptosis of human laryngocarcinoma cells via the upregulation of p53 expression
por: LI, LIANG, et al.
Publicado: (2015) -
Chitosan-Based Glycolipid Conjugated siRNA Delivery System for Improving Radiosensitivity of Laryngocarcinoma
por: Miao, Jing, et al.
Publicado: (2021) -
Intraoperative Radiotherapy for Resectable Pancreatic Cancer Using a Low-Energy X-Ray Source: Postoperative Complications and Early Outcomes
por: Cho, Yeona, et al.
Publicado: (2022)